Literature DB >> 18612390

Coronary stent healing, endothelialisation and the role of co-medication.

H M van Beusekom1, R Schoemaker, A J Roks, F Zijlstra, W J van der Giessen.   

Abstract

Year:  2007        PMID： 18612390      PMCID： PMC2442774          DOI： 10.1007/BF03086022

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  8 in total

1.  Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.

Authors:  Sjoerd H Hofma; Wim J van der Giessen; Bas M van Dalen; Pedro A Lemos; Eugene P McFadden; Georgios Sianos; Jurgen M R Ligthart; Dirk van Essen; Pim J de Feyter; Patrick W Serruys
Journal:  Eur Heart J       Date:  2005-10-25       Impact factor: 29.983

2.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

3.  Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.

Authors:  P J Mohacsi; D Tüller; B Hulliger; P L Wijngaard
Journal:  J Heart Lung Transplant       Date:  1997-05       Impact factor: 10.247

4.  Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus.

Authors:  Heleen M M van Beusekom; Francesco Saia; Jaap D Zindler; Pedro A Lemos; Stijn L Swager-Ten Hoor; Maarten A H van Leeuwen; Pim J de Feijter; Patrick W Serruys; Willem J van der Giessen
Journal:  Eur Heart J       Date:  2007-04-12       Impact factor: 29.983

5.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.

Authors:  Joost Daemen; Peter Wenaweser; Keiichi Tsuchida; Linda Abrecht; Sophia Vaina; Cyrill Morger; Neville Kukreja; Peter Jüni; Georgios Sianos; Gerrit Hellige; Ron T van Domburg; Otto M Hess; Eric Boersma; Bernhard Meier; Stephan Windecker; Patrick W Serruys
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

6.  Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.

Authors:  Mario Togni; Stephan Windecker; Rosangela Cocchia; Peter Wenaweser; Stephane Cook; Michael Billinger; Bernhard Meier; Otto M Hess
Journal:  J Am Coll Cardiol       Date:  2005-07-19       Impact factor: 24.094

7.  Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.

Authors:  Masaki Awata; Jun-ichi Kotani; Masaaki Uematsu; Takakazu Morozumi; Tetsuya Watanabe; Toshinari Onishi; Osamu Iida; Fusako Sera; Shinsuke Nanto; Masatsugu Hori; Seiki Nagata
Journal:  Circulation       Date:  2007-08-07       Impact factor: 29.690

8.  Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.

Authors:  Bas Langeveld; Wiek H van Gilst; René A Tio; Felix Zijlstra; Anton J M Roks
Journal:  Hypertension       Date:  2004-11-15       Impact factor: 10.190
  8 in total
  4 in total

1.  Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.

Authors:  Mark R Battig; Ilia Fishbein; Robert J Levy; Ivan S Alferiev; David Guerrero; Michael Chorny
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

2.  Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

Authors:  Michael Chorny; Ilia Fishbein; Benjamin B Yellen; Ivan S Alferiev; Marina Bakay; Srinivas Ganta; Richard Adamo; Mansoor Amiji; Gary Friedman; Robert J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

3.  Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors.

Authors:  Michael Chorny; Ilia Fishbein; Jillian E Tengood; Richard F Adamo; Ivan S Alferiev; Robert J Levy
Journal:  FASEB J       Date:  2013-02-13       Impact factor: 5.191

4.  Effect of a stable Angiotensin-(1-7) analogue on progenitor cell recruitment and cardiovascular function post myocardial infarction.

Authors:  Bruno Sevá Pessôa; Peter Moritz Becher; Richard Van Veghel; René De Vries; Dennie Tempel; Stefan Sneep; Heleen Van Beusekom; Vincent H J Van Der Velden; Dirk Westermann; A H Jan Danser; Anton J M Roks
Journal:  J Am Heart Assoc       Date:  2015-02-05       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.